Anti-Kickback Statute (AKS)
Whistleblower Lawsuit Ends in $25M Price-Fixing Settlement
Drugmaker allegedly conspired with competitors to manipulate drug prices
Mark Strauss
October 1, 2024
Drugmaker allegedly conspired with competitors to manipulate drug prices
A former billing manager brought the misconduct to the attention of the Justice Department by filing a False Claims Act lawsuit.
Manufacturer of home respiratory equipment allegedly coaxed DME suppliers to recommend and buy more of its products by furnishing them with two types of kickbacks—HMS prescription data and loan guarantees
Biogen allegedly spent millions illegally inducing doctors to prescribe its multiple sclerosis drugs
Qui tam whistleblower alleged that Bayer fraudulently paid kickbacks, conducted off-label marketing, and hid safety risks
Biotronik allegedly paid doctors illegal kickbacks to promote the sale of its implantable cardiac devices
Athenahealth allegedly violated the Anti-Kickback Statute (AKS) and False Claims Act by paying kickbacks for clients referrals
